Deepak Nitrite Ltd
Incorporated in 1970, Deepak Nitrite Ltd manufactures Basic Intermediates, Fine 
& Speciality Chemicals, Performance 
Products, and Phenolics[1]
- Market Cap ₹ 23,567 Cr.
- Current Price ₹ 1,728
- High / Low ₹ 2,908 / 1,725
- Stock P/E 38.8
- Book Value ₹ 395
- Dividend Yield 0.43 %
- ROCE 16.3 %
- ROE 13.4 %
- Face Value ₹ 2.00
Pros
Cons
- Dividend payout has been low at 13.1% of profits over last 3 years
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Part of BSE 500 Nifty 500 BSE MidCap BSE Allcap BSE Commodities
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,327 | 1,373 | 1,371 | 1,651 | 2,700 | 4,230 | 4,360 | 6,802 | 7,972 | 7,682 | 8,282 | 8,005 | |
| 1,187 | 1,204 | 1,231 | 1,447 | 2,278 | 3,194 | 3,108 | 5,196 | 6,680 | 6,555 | 7,187 | 7,033 | |
| Operating Profit | 140 | 169 | 139 | 204 | 421 | 1,035 | 1,252 | 1,607 | 1,292 | 1,127 | 1,095 | 972 | 
| OPM % | 11% | 12% | 10% | 12% | 16% | 24% | 29% | 24% | 16% | 15% | 13% | 12% | 
| 1 | -0 | 80 | 7 | 11 | 29 | 20 | 42 | 46 | 156 | 84 | 90 | |
| Interest | 38 | 40 | 37 | 47 | 87 | 118 | 77 | 36 | 27 | 15 | 31 | 30 | 
| Depreciation | 36 | 40 | 48 | 53 | 78 | 140 | 153 | 178 | 166 | 166 | 195 | 199 | 
| Profit before tax | 67 | 89 | 135 | 111 | 268 | 806 | 1,042 | 1,434 | 1,146 | 1,102 | 953 | 833 | 
| Tax % | 21% | 29% | 28% | 29% | 35% | 24% | 26% | 26% | 26% | 26% | 27% | |
| 53 | 63 | 96 | 79 | 174 | 611 | 776 | 1,067 | 852 | 811 | 697 | 607 | |
| EPS in Rs | 5.06 | 5.39 | 7.37 | 5.79 | 12.73 | 44.80 | 56.88 | 78.20 | 62.47 | 59.45 | 51.12 | 44.50 | 
| Dividend Payout % | 20% | 22% | 16% | 22% | 16% | 10% | 10% | 9% | 12% | 13% | 15% | 
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 20% | 
| 5 Years: | 14% | 
| 3 Years: | 7% | 
| TTM: | -1% | 
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 29% | 
| 5 Years: | 2% | 
| 3 Years: | -14% | 
| TTM: | -25% | 
| Stock Price CAGR | |
|---|---|
| 10 Years: | 38% | 
| 5 Years: | 18% | 
| 3 Years: | -9% | 
| 1 Year: | -34% | 
| Return on Equity | |
|---|---|
| 10 Years: | 23% | 
| 5 Years: | 23% | 
| 3 Years: | 17% | 
| Last Year: | 13% | 
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 21 | 23 | 26 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 
| Reserves | 325 | 450 | 689 | 895 | 1,044 | 1,545 | 2,319 | 3,311 | 4,063 | 4,769 | 5,361 | 
| 545 | 529 | 724 | 987 | 1,187 | 1,107 | 590 | 315 | 73 | 286 | 1,267 | |
| 235 | 295 | 350 | 684 | 677 | 538 | 630 | 779 | 967 | 1,012 | 1,053 | |
| Total Liabilities | 1,125 | 1,296 | 1,789 | 2,592 | 2,935 | 3,217 | 3,567 | 4,432 | 5,129 | 6,095 | 7,708 | 
| 549 | 594 | 586 | 588 | 1,716 | 1,832 | 1,864 | 1,963 | 1,942 | 2,293 | 2,457 | |
| CWIP | 44 | 36 | 349 | 955 | 34 | 172 | 220 | 122 | 301 | 774 | 1,649 | 
| Investments | 3 | 87 | 118 | 32 | 2 | 2 | 189 | 439 | 379 | 122 | 511 | 
| 530 | 580 | 736 | 1,018 | 1,183 | 1,210 | 1,293 | 1,908 | 2,508 | 2,907 | 3,091 | |
| Total Assets | 1,125 | 1,296 | 1,789 | 2,592 | 2,935 | 3,217 | 3,567 | 4,432 | 5,129 | 6,095 | 7,708 | 
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 108 | 167 | 49 | 183 | 60 | 765 | 1,002 | 824 | 650 | 874 | 625 | |
| -89 | -169 | -353 | -525 | -163 | -428 | -396 | -424 | -276 | -717 | -1,489 | |
| -22 | 4 | 305 | 345 | 96 | -338 | -599 | -386 | -359 | 44 | 806 | |
| Net Cash Flow | -3 | 2 | 1 | 4 | -6 | -1 | 7 | 14 | 15 | 200 | -59 | 
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 86 | 83 | 96 | 91 | 78 | 53 | 63 | 61 | 60 | 62 | 56 | 
| Inventory Days | 47 | 54 | 75 | 118 | 94 | 63 | 64 | 53 | 62 | 54 | 59 | 
| Days Payable | 48 | 59 | 95 | 176 | 106 | 57 | 72 | 46 | 46 | 38 | 33 | 
| Cash Conversion Cycle | 85 | 79 | 76 | 32 | 66 | 59 | 56 | 67 | 76 | 77 | 82 | 
| Working Capital Days | -3 | -28 | -49 | -29 | 35 | 33 | 57 | 57 | 70 | 70 | 64 | 
| ROCE % | 14% | 8% | 10% | 17% | 38% | 40% | 44% | 30% | 22% | 16% | 
Documents
Announcements
- 
        
          Board Meeting Intimation for Consider And Approve The Standalone And Consolidated Un-Audited Financial Results Of The Company For The Quarter And Half Year Ended 30Th September, 2025.
          
            28 Oct - Board meeting on 12 Nov 2025 to approve unaudited Q2/H1 results ended 30 Sep 2025.
- 
        
          Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
          
            17 Oct - DCTL allotted 40,00,000 9% OCRPS (₹40.00 crore) to sister subsidiary DPL on Oct 17, 2025.
- 
        
          Disclosure Under Regulation 30 Of SEBI (LODR), Regulations, 2015
          
            9 Oct - GST order dated Oct 8, 2025: recovery and penalty INR 2,15,34,798 against Deepak Phenotics (DPL).
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 Oct
- 
        
          Press Release
          
            6 Oct - Inauguration of 5-acre DRDC 2.0 R&D centre at Savli, Vadodara on 06 Oct 2025.
Annual reports
- 
    
      Financial Year 2025
      from bse
- 
    
      Financial Year 2024
      from bse
- 
    
      Financial Year 2023
      from bse
- 
    
      Financial Year 2022
      from bse
- 
    
      Financial Year 2021
      from bse
- 
    
      Financial Year 2020
      from bse
- 
    
      Financial Year 2019
      from bse
- 
    
      Financial Year 2018
      from bse
- 
    
      Financial Year 2017
      from bse
- 
    
      Financial Year 2016
      from bse
- 
    
      Financial Year 2015
      from bse
- 
    
      Financial Year 2014
      from bse
- 
    
      Financial Year 2013
      from bse
- 
    
      Financial Year 2012
      from bse
- 
    
      Financial Year 2012
      from nse
Concalls
- 
      Aug 2025Transcript PPT
- 
      Jun 2025Transcript PPT
- 
      Feb 2025Transcript PPT
- 
      Nov 2024Transcript PPT REC
- 
      Aug 2024Transcript PPT
- 
      May 2024Transcript PPT REC
- 
      Feb 2024Transcript PPT REC
- 
      Nov 2023Transcript PPT
- 
      Aug 2023Transcript PPT
- 
      Aug 2023TranscriptNotesPPT
- 
      May 2023Transcript PPT REC
- 
      May 2023TranscriptNotesPPT
- 
      Feb 2023Transcript PPT
- 
      Nov 2022TranscriptPPT
- 
      Aug 2022Transcript PPT
- 
      May 2022TranscriptPPT
- 
      Jan 2022TranscriptPPT
- 
      Oct 2021TranscriptPPT
- 
      Aug 2021TranscriptPPT
- 
      May 2021TranscriptPPT
- 
      Feb 2021Transcript PPT
- 
      Oct 2020TranscriptNotesPPT
- 
      Aug 2020TranscriptNotesPPT
- 
      May 2020TranscriptNotesPPT
- 
      Feb 2020TranscriptNotesPPT
- 
      Oct 2019TranscriptNotesPPT
- 
      Aug 2019TranscriptNotesPPT
- 
      May 2019TranscriptNotesPPT
- 
      Feb 2019TranscriptNotesPPT
- 
      Oct 2018TranscriptNotesPPT
- 
      Aug 2018TranscriptNotesPPT
- 
      May 2018TranscriptNotesPPT
- 
      Jan 2018TranscriptNotesPPT
- 
      Nov 2017TranscriptNotesPPT
- 
      Aug 2017TranscriptNotesPPT
- 
      Feb 2017TranscriptNotesPPT
Business Segments
The company is one of the fastest growing chemical intermediates company in India with a portfolio of 32+ products and 56+ applications, divided into 2 segments: [1]